A case report of drug-induced liver injury due to the infliximab biosimilar CT-P13 on switching from original infliximab in a patient with Crohn’s disease

Inflammatory bowel diseases (IBDs) are chronic immune disorders of unclear etiology. Tumor necrosis factor (TNF) inhibitors are effective for IBD treatment and are cost-effective because they reduce hospital admissions and are associated with fewer surgery requirements and a better quality of life i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashima, Shin, Sawada, Koji, Moriichi, Kentaro, Fujiya, Mikihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136431/
https://www.ncbi.nlm.nih.gov/pubmed/35646305
http://dx.doi.org/10.1177/20420986221100118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136431/
https://www.ncbi.nlm.nih.gov/pubmed/35646305
http://dx.doi.org/10.1177/20420986221100118

Ejemplares similares